KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Operating Leases (2019 - 2025)

Evolent Health has reported Operating Leases over the past 7 years, most recently at $19.2 million for Q4 2025.

  • Quarterly results put Operating Leases at $19.2 million for Q4 2025, down 23.26% from a year ago — trailing twelve months through Dec 2025 was $19.2 million (down 23.26% YoY), and the annual figure for FY2025 was $19.2 million, down 23.26%.
  • Operating Leases for Q4 2025 was $19.2 million at Evolent Health, up from $4.4 million in the prior quarter.
  • Over the last five years, Operating Leases for EVH hit a ceiling of $67.8 million in Q1 2021 and a floor of $4.4 million in Q3 2025.
  • Median Operating Leases over the past 5 years was $54.3 million (2022), compared with a mean of $45.7 million.
  • Peak annual rise in Operating Leases hit 12.41% in 2025, while the deepest fall reached 87.53% in 2025.
  • Evolent Health's Operating Leases stood at $57.7 million in 2021, then dropped by 2.97% to $56.0 million in 2022, then crashed by 32.14% to $38.0 million in 2023, then tumbled by 34.31% to $25.0 million in 2024, then dropped by 23.26% to $19.2 million in 2025.
  • The last three reported values for Operating Leases were $19.2 million (Q4 2025), $4.4 million (Q3 2025), and $8.4 million (Q2 2025) per Business Quant data.